Jun 19, 2026
15 MIN READ

What Is the Average Weight Loss on Zepbound Per Month?

Zepbound users typically lose 1–2 pounds per week in early months, with cumulative weight reduction reaching 15–22% of baseline body weight by 68 weeks in clinical trials. Individual results vary based on genetics, diet, exercise, and medication tolerance.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 19, 2026
15 MIN READ

what is the average weight loss on zepbound per month? — PlexusDx GLP-1 education

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Zepbound (tirzepatide) is a dual GLP-1 and GIP receptor agonist that reduces appetite and blood sugar simultaneously, leading to consistent monthly weight loss for many patients. Clinical trial data shows participants lose an average of 4–8 pounds per month during the first three months, though this pace may slow as treatment continues. Understanding realistic expectations helps you set sustainable goals and track meaningful progress over time.

Typical Monthly Weight Loss Patterns on Zepbound

Zepbound produces the most dramatic weight reduction during months one through three, when appetite suppression is strongest and metabolic adjustments occur. Most patients report losing between 4 and 8 pounds in the first 30 days, with additional losses of 2–4 pounds per month as doses increase and the body adapts. By month four, weight loss typically stabilizes at a slower but sustainable rate of 1–3 pounds weekly.

Clinical trials tracked tirzepatide's long-term impact across 68 weeks of continuous treatment. Participants on the highest effective doses achieved average total weight reductions of 20–22% of their starting body weight, translating to roughly 50–80 pounds for someone beginning at 250 pounds. This means monthly averages decline over time: rapid early loss gives way to gradual but consistent reduction as the body reaches a new equilibrium.

Clinical Trial Data: Zepbound Weight Loss Results

The SURMOUNT-1 trial enrolled over 2,600 adults with obesity and tracked tirzepatide's effectiveness against placebo over 68 weeks. Participants receiving the 15mg maintenance dose lost an average of 22.5% of their body weight, while those on placebo lost only 2.4%. This 20-percentage-point difference underscores tirzepatide's potency as a pharmaceutical weight-loss intervention.

Monthly breakdowns from trial data reveal that the steepest decline occurs between weeks one and 12, where patients lose roughly 6–8% of baseline weight. Weeks 13–24 show a moderation to 3–4% monthly losses, while weeks 25–68 establish a pattern of 1–2% monthly reductions. This deceleration is normal and reflects the body's metabolic adaptation rather than medication failure.

Factors That Influence Your Individual Monthly Weight Loss

Genetic variation in appetite-control pathways significantly affects how quickly your body responds to tirzepatide. PlexusDx's Precision Peptide Genetic Test examines key variants in the GLP1R, GIPR, FTO, and MC4R genes—regions that code for receptors and metabolic regulators directly targeted by tirzepatide therapy. Patients with certain genetic profiles may experience faster initial losses or reach higher total reductions than population averages.

Beyond genetics, diet quality, physical activity, sleep patterns, and baseline metabolic rate shape your month-to-month progress. Someone combining tirzepatide with consistent calorie deficit and regular exercise typically loses weight faster than someone relying on medication alone. Stress levels and medication adherence also matter: inconsistent injection timing or frequent high-calorie meals can dampen results, while structured eating and stress management amplify them.

Age, starting body weight, and presence of metabolic conditions like type 2 diabetes influence the trajectory as well. Older adults may lose weight more slowly than younger patients, while those with higher baseline weights often experience larger absolute monthly losses during early treatment phases. Individuals with diabetes may see additional metabolic benefits beyond weight reduction.

What Happens After Month One on Tirzepatide Therapy

The first month on tirzepatide typically delivers the most noticeable results, but this reflects rapid fluid loss, reduced food volume in the digestive tract, and initial metabolic changes rather than exclusively fat loss. As your body adjusts to suppressed appetite signals, monthly weight loss naturally decelerates—a pattern observed consistently across clinical trials and real-world patient data. This is not a sign that the medication is failing; rather, it indicates your body is stabilizing at a new, lower set point.

PlexusDx tirzepatide injections begin at $249 per month, with your dose potentially increasing over 12–16 weeks to reach therapeutic targets—but your price remains flat throughout. This commitment means you can pursue optimal dosing without worrying about escalating costs. Pairing tirzepatide therapy with the Precision Peptide Genetic Test ($99 add-on after your first month) gives you a personalized roadmap of your genetic predispositions, helping PlexusDx providers refine your treatment plan for maximum results aligned with your biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How many pounds per month can I expect to lose on Zepbound?

During months one through three, most patients lose 4–8 pounds monthly. After that, losses typically decline to 2–4 pounds per month as the body adapts. By month six and beyond, you may see 1–3 pounds of loss weekly, or roughly 4–12 pounds per month. Total weight loss by 68 weeks averages 20–22% of starting body weight in clinical trials.

Why does weight loss slow down after the first month?

Initial rapid loss includes fluid reduction and decreased stomach contents, which naturally stabilize as your body adapts to the appetite-suppressing effects of tirzepatide. This deceleration is expected and healthy. Continued gradual loss reflects sustained fat reduction and metabolic adjustment rather than medication failure.

Does PlexusDx tirzepatide cost more if I need higher doses?

No. PlexusDx compounded tirzepatide injections are priced at a flat $249 per month regardless of dose level. Your dose may need to go up. Your price won't. This applies across all commitment tiers and includes HSA/FSA eligibility.

Can genetics predict how much weight I'll lose on tirzepatide?

Partially. PlexusDx's Precision Peptide Genetic Test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and metabolic response. These genetic insights help your provider anticipate your body's response pattern and adjust treatment strategy, though lifestyle factors like diet and exercise also significantly impact monthly outcomes.

Is tirzepatide safer than semaglutide for weight loss?

Tirzepatide activates two pathways (GLP-1 and GIP receptors) versus semaglutide's single pathway, which may explain its larger average weight losses in trials. Both are prescribed for weight management and carry similar side-effect profiles (nausea, vomiting, constipation). PlexusDx offers both compounded semaglutide and tirzepatide injections so your provider can recommend the best fit for your health history and goals.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves